Genomic Valley Biotech Ltd
company logo

Genomic Valley Biotech Ltd

Genomic Valley Share Price

Miscellaneous
Small Cap

-

0 (0%)

Start Investing in Genomic Valley Biotech Ltd

*By signing up you agree to our Terms and Conditions

Genomic Valley Biotech Ltd Performance

-

-

-

-


-

-

-

-

-

Genomic Valley Biotech Ltd Fundamentals

31.38Cr

123.80

8.22

0

0.83

0%

12.50

i buttonClick here to know more about Fundamentals

Genomic Valley Biotech Ltd Financials

Genomic Valley Biotech Ltd Financialsright-arrow

Genomic Valley Biotech Ltd Shareholding Pattern

Genomic Valley Biotech Ltd Delivery and Volume

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market n

Yogesh Agrawal

1994

-

NameDesignation
Yogesh AgrawalChairman & Managing Director
Parul AgrawalDirector
Kapoor Chand GargAddtnl Independent Director
RAHUL KUMAR PATHAKAddtnl Independent Director
Gupta PradeepIndependent Director
Jyoti BansalAdditional Director
praveen Kumar MishraAdditional Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Genomic Valley Biotech Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Genomic Valley Biotech Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Genomic Valley Biotech Ltd's share price is ₹104.5 as of 2024-11-05.
Genomic Valley Biotech Ltd's P/E ratio is 123.8 times as of 2024-11-05.
Genomic Valley Biotech Ltd's most recent financial reports indicate a price-to-book ratio of 8.22, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Genomic Valley Biotech Ltd's market capitalization is ₹31.38 Cr as on 2024-11-05.
The current financial records of Genomic Valley Biotech Ltd show a 28.48% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Genomic Valley Biotech Ltd's most recent financial filings, the company has a total asset value of ₹2.58, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Genomic Valley Biotech Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Genomic Valley Biotech Ltd's 52-week high and low as of 2024-11-05 are ₹104.8 and ₹104.5, respectively.